Research Progress of G-protein Coupled Receptor 119 Agonists

蒋坤,江程,王举波,宋丽君,李志裕
2012-01-01
Abstract:G-protein-coupled receptor 119(GPR119) has emerged as one of the most exciting targets for the treatment of type 2 diabetes.GPR119 agonists mediate a unique nutrient-dependent dual elevation of both insulin and glucagon like peptide 1/glucose-dependant insulinotropic peptide levels in vivo.Many pharmaceutical companies have focused on this target,several GPR119 agonists have been reported,and some of them entered clinical trials.In this article,the recent research progress of GPR119 agonists is reviewed.
What problem does this paper attempt to address?